Combination therapy with type I and type II anti-CD20 antibodies

• 收藏
• 分享

专利权人:

ロシュ グリクアート アクチェンゲゼルシャフト;エフ．ホフマン－ラ ロシュ アーゲー;エフ.ホフマン-ラ ロシュ アーゲー

发明人:

フリース，トマス,クライン，クリスティアン,ウマナ，パブロ,フリース,トマス,クライン,クリスティアン,ウマナ,パブロ

申请号：

JP2010523297

公开号：

JP5209723B2

申请日:

2008.08.20

申请国别(地区):

JP

年份:

2013

代理人:

摘要：

The present invention is directed to a combination therapy involving a type I anti-CD20 antibody and a type II anti-CD20 antibody for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. An aspect of the invention is a composition comprising a type I anti-CD20 antibody and a type II anti-CD20 antibody. Another aspect of the invention is a kit comprising a type I anti-CD20 antibody and a type II anti-CD20 antibody. Yet another aspect of the invention is a method for the treatment of a patient suffering from cancer comprising co-administering, to a patient in need of such treatment, a type I anti-CD20 antibody and a type II anti-CD20 antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/